| |
About QuantRx® Biomedical
QuantRx Biomedical Corporation is an emerging leader in the development of products for advanced diagnosis of serious disease and health conditions. With synergistic expertise in the discovery of diagnostic platforms and the commercialization of products for use by medical professionals, institutions, and consumers, QuantRx is focused on providing more accurate, reliable, and faster diagnoses that result in improved patient care.The QuantRx strategy is one of sustained growth and targets significant market opportunities estimated to be in excess of $4 billion worldwide.
|
|
|
QuantRx Announces Positive Phase I Safety Results for BFPET™, Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) by FluoroPharma
QuantRx Announces Multi Year Agreement with CytoCore for Exclusive Distribution of QuantRx’s PADKit® for Cytology and Human Papilloma Virus
|
July 29th – 31st
American Association of Clinical Chemists Washington D.C.
www.aacc.org |
|
|
|
